Latest filing published 18 Aug 2026 for Hims & Hers Health, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Irene Becklund is a declared insider of Hims & Hers Health, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 54 filings cover trades dated from 15 December 2021 to 14 August 2026.
Sales make up the whole of the open-market record (24 sales, €2.2M). No amount is published for 2 filings, which the totals therefore leave out. Outside the open market, there are 2 share grants and 28 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The record was last updated on 18 August 2026 with an option exercise in Hims & Hers Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations